Landfar Bio-medicine Co., Ltd. Class A (000504.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.87B
Enterprise Value2.85B
P/E Ratio71.11
PEG Ratio0.05
Price/Sales Ratio4.16
Price/Book Ratio10.1
Enterprise/Revenue4.02
Enterprise/EBITDA66.89

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.06
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.15

Income Statement

Revenue415.94M
Revenue/Share2
Gross Profit91.8M
EBITDA29.14M
Net Income28.83M
Diluted EPS0.09

Balance Sheet

Total Cash308.97M
Total Cash/Share0.94
Total Debt216.94M
Total Debt/Equity0.8
Current Ratio1.45
Book Value Per Share1.09

Price History

52-Week Change-20.91
52-Week High10.68
52-Week Low7.02
Moving Average 50 Days8.25
Moving Average 200 Days8.86

Statistics

Average Volume7.88M
Shares Outstanding330.02M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.03
Last Split Factor13:10
Last Split DateJanuary 15, 2007
AD